{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T15:26:19Z","timestamp":1789140379880,"version":"build-2803163510"},"reference-count":180,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010751","name":"FONDECYT","doi-asserted-by":"publisher","award":["1191874"],"award-info":[{"award-number":["1191874"]}],"id":[{"id":"10.13039\/501100010751","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002850","name":"Fondo Nacional de Desarrollo Cient\u00edfico y Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.jaut.2021.102702","type":"journal-article","created":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T09:00:38Z","timestamp":1627030838000},"page":"102702","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Cellular and molecular regulation of the programmed death-1\/programmed death ligand system and its role in multiple sclerosis and other autoimmune diseases"],"prefix":"10.1016","volume":"123","author":[{"given":"Jorge","family":"Iba\u00f1ez-Vega","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0228-7549","authenticated-orcid":false,"given":"Constanza","family":"Vilchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1180-1802","authenticated-orcid":false,"given":"Karin","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8635-3792","authenticated-orcid":false,"given":"Carlos","family":"Guevara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula I.","family":"Burgos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1203-3593","authenticated-orcid":false,"given":"Rodrigo","family":"Naves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2021.102702_bib1","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.3389\/fimmu.2017.01514","article-title":"Update on dendritic cell-induced immunological and clinical tolerance","volume":"8","author":"Obregon","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2021.102702_bib2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/978-981-32-9717-3_2","article-title":"The CD28\u2013B7 family of co-signaling molecules","volume":"1189","author":"Nagai","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jaut.2021.102702_bib3","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3389\/fimmu.2020.00339","article-title":"Progress and challenges in precise treatment of tumors with PD-1\/PD-L1 blockade","volume":"11","author":"Jiang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2021.102702_bib4","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1158\/0008-5472.CAN-19-3133","article-title":"Targeting glycosylated PD-1 induces potent anti-tumor immunity","author":"Sun","year":"2020","journal-title":"Canc. Res."},{"key":"10.1016\/j.jaut.2021.102702_bib5","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.coi.2011.12.009","article-title":"Targeting the PD-1\/B7-H1(PD-L1) pathway to activate anti-tumor immunity","volume":"24","author":"Topalian","year":"2012","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jaut.2021.102702_bib6","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s40425-019-0770-2","article-title":"Mechanisms regulating PD-L1 expression on tumor and immune cells","volume":"7","author":"Chen","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jaut.2021.102702_bib7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cellimm.2016.09.009","article-title":"PD-1\/PD-L and autoimmunity: a growing relationship","volume":"310","author":"Zamani","year":"2016","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.jaut.2021.102702_bib8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1749-6632.2010.05919.x","article-title":"The role of the PD-1 pathway in autoimmunity and peripheral tolerance","volume":"1217","author":"Fife","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jaut.2021.102702_bib9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.clim.2014.04.010","article-title":"Programmed death-1 pathway in cancer and autoimmunity","volume":"153","author":"Pedoeem","year":"2014","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jaut.2021.102702_bib10","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/978-981-32-9717-3_9","article-title":"Co-signaling molecules in neurological diseases","volume":"1189","author":"Kivis\u00e4kk","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jaut.2021.102702_bib11","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s13760-012-0061-x","article-title":"Self-tolerance in multiple sclerosis","volume":"112","author":"Gonsette","year":"2012","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.jaut.2021.102702_bib12","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1600-065X.2012.01136.x","article-title":"Immune checkpoints in central nervous system autoimmunity","volume":"248","author":"Joller","year":"2012","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jaut.2021.102702_bib13","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/ana.20514","article-title":"A PD-1 polymorphism is associated with disease progression in multiple sclerosis","volume":"58","author":"Kroner","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jaut.2021.102702_bib14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jneuroim.2017.02.006","article-title":"PD-1 gene polymorphic variation is linked with first symptom of disease and severity of relapsing-remitting form of MS","volume":"305","author":"Pawlak-Adamska","year":"2017","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jaut.2021.102702_bib15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00251-017-1015-5","article-title":"PD-1 and cancer: molecular mechanisms and polymorphisms","volume":"70","author":"Salmaninejad","year":"2018","journal-title":"Immunogenetics"},{"key":"10.1016\/j.jaut.2021.102702_bib16","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","article-title":"PD-1 and its ligands in tolerance and immunity","volume":"26","author":"Keir","year":"2008","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jaut.2021.102702_bib17","doi-asserted-by":"crossref","first-page":"111876","DOI":"10.1016\/j.ejmech.2019.111876","article-title":"Progress in PD-1\/PD-L1 pathway inhibitors: from biomacromolecules to small molecules","volume":"186","author":"Lin","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jaut.2021.102702_bib18","doi-asserted-by":"crossref","first-page":"97671","DOI":"10.18632\/oncotarget.18311","article-title":"Soluble PD-1 and PD-L1: predictive and prognostic significance in cancer","volume":"8","author":"Zhu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jaut.2021.102702_bib19","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1186\/s13075-015-0859-z","article-title":"Soluble PD-1 aggravates progression of collagen-induced arthritis through Th1 and Th17 pathways","volume":"17","author":"Liu","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2021.102702_bib20","first-page":"408","article-title":"Soluble PD-1 is associated with aberrant regulation of T cells activation in aplastic anemia, Immunol","volume":"38","author":"Wu","year":"2009","journal-title":"Invest"},{"key":"10.1016\/j.jaut.2021.102702_bib21","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/cei.12949","article-title":"Inflammatory cytokines compromise programmed cell death-1 (PD-1)-mediated T cell suppression in inflammatory arthritis through up-regulation of soluble PD-1","volume":"188","author":"Bommarito","year":"2017","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2021.102702_bib22","doi-asserted-by":"crossref","first-page":"4372","DOI":"10.1074\/jbc.AC119.011747","article-title":"The structural features that distinguish PD-L2 from PD-L1 emerged in placental mammals","volume":"295","author":"Philips","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jaut.2021.102702_bib23","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.immuni.2017.11.021","article-title":"Transcription factor IRF4 promotes CD8+ T cell exhaustion and limits the development of memory-like T cells during chronic infection","volume":"47","author":"Man","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2021.102702_bib24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-981-32-9717-3_1","article-title":"Co-signal molecules in T-Cell Activation: historical overview and perspective","volume":"1189","author":"Azuma","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jaut.2021.102702_bib25","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.immuni.2016.01.018","article-title":"Glycogen synthase kinase 3 inactivation drives T-bet-mediated downregulation of Co-receptor PD-to enhance CD8+ cytolytic T cell responses","volume":"44","author":"Taylor","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2021.102702_bib26","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.4049\/jimmunol.1003208","article-title":"IFN-\u03b1 directly promotes programmed cell death-1 transcription and limits the duration of T cell-mediated immunity","volume":"186","author":"Terawaki","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2021.102702_bib27","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.RA119.010379","article-title":"Glucocorticoids potentiate the inhibitory capacity of programmed cell death 1 by up-regulating its expression on T cells","volume":"294","author":"Maeda","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jaut.2021.102702_bib28","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.3390\/ijms18122540","article-title":"The roles of microRNAs in regulating the expression of PD-1\/PD-L1 immune checkpoint","volume":"18","author":"Wang","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jaut.2021.102702_bib29","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1483302","article-title":"H3K4me3 mediates the NF-\u03baB p50 homodimer binding to the pdcd1 promoter to activate PD-1 transcription in T cells","volume":"7","author":"Redd","year":"2018","journal-title":"OncoImmunology"},{"key":"10.1016\/j.jaut.2021.102702_bib30","doi-asserted-by":"crossref","first-page":"449","DOI":"10.4049\/jimmunol.1900601","article-title":"PD-1 expression during acute infection is repressed through an LSD1\u2013blimp-1 Axis","volume":"204","author":"Bally","year":"2020","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2021.102702_bib31","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ebiom.2018.01.016","article-title":"PD-1 (PDCD1) promoter methylation is a prognostic factor in patients with diffuse lower-grade gliomas harboring isocitrate dehydrogenase (IDH) mutations","volume":"28","author":"R\u00f6ver","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jaut.2021.102702_bib32","doi-asserted-by":"crossref","first-page":"9612","DOI":"10.18632\/oncotarget.3324","article-title":"Hypomethylation and up-regulation of PD-1 in T cells by azacytidine in MDS\/AML patients: a rationale for combined targeting of PD-1 and DNA methylation","volume":"6","author":"\u00d8rskov","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jaut.2021.102702_bib33","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.celrep.2017.04.031","article-title":"Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression","volume":"19","author":"Garcia-Diaz","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.jaut.2021.102702_bib34","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1038\/s41467-020-15364-z","article-title":"NPM1 upregulates the transcription of PD-L1 and suppresses T cell activity in triple-negative breast cancer","volume":"11","author":"Qin","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jaut.2021.102702_bib35","first-page":"1891","article-title":"Interferon regulatory factor 1 (IRF-1) and IRF-2 regulate PD-L1 expression in hepatocellular carcinoma (HCC ) cells, Cancer Immunol","volume":"1","author":"Yan","year":"2020","journal-title":"Immunotherapy"},{"key":"10.1016\/j.jaut.2021.102702_bib36","doi-asserted-by":"crossref","first-page":"11697","DOI":"10.1038\/s41598-019-48256-4","article-title":"Myeloid maturation potentiates STAT3-mediated atypical IFN-\u03b3 signaling and upregulation of PD-1 ligands in AML and MDS","volume":"9","author":"Yoyen-Ermis","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jaut.2021.102702_bib37","doi-asserted-by":"crossref","first-page":"704","DOI":"10.4049\/jimmunol.1800876","article-title":"BCL6-Mediated silencing of PD-1 ligands in germinal center B cells maintains follicular T cell population","volume":"202","author":"Peng","year":"2019","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2021.102702_bib38","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1158\/2326-6066.CIR-15-0077-T","article-title":"HDAC inhibition upregulates PD-1 ligands in melanoma and augments immunotherapy with PD-1 blockade","volume":"3","author":"Woods","year":"2015","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.jaut.2021.102702_bib39","first-page":"1223","article-title":"PD-L1 gene promoter methylation represents a potential diagnostic marker in advanced gastric cancer","volume":"19","author":"Lv","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.jaut.2021.102702_bib40","doi-asserted-by":"crossref","first-page":"106245","DOI":"10.1016\/j.intimp.2020.106245","article-title":"Epigenetically silenced PD-L1 confers drug resistance to anti-PD1 therapy in gastric cardia adenocarcinoma","volume":"82","author":"Zhu","year":"2020","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.jaut.2021.102702_bib41","doi-asserted-by":"crossref","first-page":"7126","DOI":"10.1074\/jbc.RA120.013401","article-title":"The polymorphism rs975484 in the protein arginine methyltransferase 1 gene modulates expression of immune checkpoint genes in hepatocellular carcinoma","volume":"295","author":"Schonfeld","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jaut.2021.102702_bib42","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1158\/2326-6066.CIR-19-0696","article-title":"Long noncoding RNAs control the modulation of immune checkpoint molecules in cancer","volume":"8","author":"Xu","year":"2020","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.jaut.2021.102702_bib43","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.celrep.2018.12.014","article-title":"Microtubule-driven stress granule dynamics regulate inhibitory immune checkpoint expression in T cells","volume":"26","author":"Franchini","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.jaut.2021.102702_bib44","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/s41563-019-0371-y","article-title":"A mechano-signalling network linking microtubules, myosin IIA filaments and integrin-based adhesions","volume":"18","author":"Rafiq","year":"2019","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jaut.2021.102702_bib45","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.celrep.2017.07.027","article-title":"Blockage of core fucosylation reduces cell-surface expression of PD-1 and promotes anti-tumor immune responses of T cells","volume":"20","author":"Okada","year":"2017","journal-title":"cell rep"},{"key":"10.1016\/j.jaut.2021.102702_bib46","doi-asserted-by":"crossref","first-page":"17765","DOI":"10.1073\/pnas.0708767104","article-title":"Programmed death-1 concentration at the immunological synapse is determined by ligand affinity and availability","volume":"104","author":"Pentcheva-Hoang","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jaut.2021.102702_bib47","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41586-018-0756-0","article-title":"FBXO38 mediates PD-1 ubiquitination and regulates anti-tumour immunity of T cells","volume":"564","author":"Meng","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2021.102702_bib48","doi-asserted-by":"crossref","first-page":"20257","DOI":"10.1038\/s41598-019-56208-1","article-title":"c-Cbl targets PD-1 in immune cells for proteasomal degradation and modulates colorectal tumor growth","volume":"9","author":"Lyle","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jaut.2021.102702_bib49","doi-asserted-by":"crossref","first-page":"6349","DOI":"10.1158\/0008-5472.CAN-18-1892","article-title":"Posttranslational modifications of PD-L1 and their applications in cancer therapy","volume":"78","author":"Hsu","year":"2018","journal-title":"Canc. Res."},{"key":"10.1016\/j.jaut.2021.102702_bib50","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13046-019-1148-5","article-title":"Autophagy inhibition enhances PD-L1 expression in gastric cancer","volume":"38","author":"Wang","year":"2019","journal-title":"J. Exp. Clin. Canc. Res."},{"key":"10.1016\/j.jaut.2021.102702_bib51","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41551-019-0375-6","article-title":"Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours","volume":"3","author":"Yao","year":"2019","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jaut.2021.102702_bib52","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/mc.23176","article-title":"EGFR-ERK pathway regulates CSN6 to contribute to PD-L1 expression in glioblastoma","volume":"59","author":"Su","year":"2020","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.jaut.2021.102702_bib53","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41589-018-0161-x","article-title":"HIP1R targets PD-L1 to lysosomal degradation to alter T cell\u2013mediated cytotoxicity","volume":"15","author":"Wang","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jaut.2021.102702_bib54","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1158\/1078-0432.CCR-10-0250","article-title":"Identification of a soluble form of B7-H1 that retains immunosuppressive activity and is associated with aggressive renal cell carcinoma","volume":"17","author":"Frigola","year":"2011","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.jaut.2021.102702_bib55","first-page":"78","article-title":"Soluble B7-H1: differences in production between dendritic cells and T cells, Immunol","volume":"23","author":"Xavier Frigola","year":"2012","journal-title":"Letture"},{"key":"10.1016\/j.jaut.2021.102702_bib56","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.4049\/jimmunol.1403143","article-title":"Imaging of cell\u2013cell communication in a vertical orientation reveals high-resolution structure of immunological synapse and novel PD-1 dynamics","volume":"195","author":"Jang","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2021.102702_bib57","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/978-981-32-9717-3_5","article-title":"Molecular dynamics of co-signal molecules in T-cell activation","volume":"1189","author":"Saito","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jaut.2021.102702_bib58","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/ni.1790","article-title":"Interactions between programmed death-1 and programmed death ligand-1 promote tolerance by blocking the T cell receptor-induced stop signal","volume":"10","author":"Fife","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2021.102702_bib59","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1126\/science.aaf1292","article-title":"T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition","volume":"355","author":"Hui","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.jaut.2021.102702_bib60","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1126\/science.aav7062","article-title":"Restriction of PD-1 function by cis-PD-L1\/CD80 interactions is required for optimal T cell responses","volume":"364","author":"Sugiura","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.jaut.2021.102702_bib61","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.3389\/fimmu.2018.02569","article-title":"T-cell exhaustion in chronic infections: reversing the state of exhaustion and reinvigorating optimal protective immune responses","volume":"9","author":"Saeidi","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2021.102702_bib62","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3389\/fimmu.2020.00467","article-title":"PD-1-Mediated PI3K\/Akt\/mTOR, caspase 9\/caspase 3 and ERK pathways are involved in regulating the apoptosis and proliferation of CD4+ and CD8+ T cells during BVDV infection in vitro","volume":"11","author":"Liu","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2021.102702_bib63","doi-asserted-by":"crossref","first-page":"6692","DOI":"10.1038\/ncomms7692","article-title":"PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation","volume":"6","author":"Patsoukis","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jaut.2021.102702_bib64","doi-asserted-by":"crossref","first-page":"10691","DOI":"10.1073\/pnas.0307252101","article-title":"PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells","volume":"101","author":"Latchman","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jaut.2021.102702_bib65","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/ni1165","article-title":"Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4","volume":"6","author":"Probst","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2021.102702_bib66","doi-asserted-by":"crossref","first-page":"9331","DOI":"10.1073\/pnas.0710441105","article-title":"Programmed death 1 ligand signaling regulates the generation of adaptative Foxp3+CD4+ regulatory T Cells","volume":"105","author":"Wang","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jaut.2021.102702_bib67","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1084\/jem.20090847","article-title":"PD-L1 regulates the development, maintenance, and function of induced regulatory T cells","volume":"206","author":"Francisco","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2021.102702_bib68","doi-asserted-by":"crossref","first-page":"363674","DOI":"10.1038\/s41598-018-21861-5","article-title":"FoxP3 isoforms and PD-1 expression by T regulatory cells in multiple sclerosis","volume":"8","author":"Sambucci","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jaut.2021.102702_bib69","first-page":"111","article-title":"The PDL1-PD1 Axis converts human Th1 cells into regulatory T cells","volume":"3","author":"Amarnath","year":"2011","journal-title":"Immunology"},{"key":"10.1016\/j.jaut.2021.102702_bib70","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.immuni.2018.05.006","article-title":"PD-1 inhibitory receptor downregulates asparaginyl endopeptidase and maintains Foxp3 transcription factor stability in induced regulatory T cells","volume":"49","author":"Stathopoulou","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2021.102702_bib71","first-page":"134","article-title":"Multiple sclerosis - a quiet revolution","volume":"11","author":"Ransohoff","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2021.102702_bib72","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS, third edition","volume":"26","author":"Walton","year":"2020","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.jaut.2021.102702_bib73","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/B978-0-444-52001-2.00014-5","article-title":"The clinical course of multiple sclerosis","volume":"122","author":"Confavreux","year":"2014","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.jaut.2021.102702_bib74","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1474-4422(14)70256-X","article-title":"Pathological mechanisms in progressive multiple sclerosis","volume":"14","author":"Mahad","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jaut.2021.102702_bib75","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/ene.12798","article-title":"A basic overview of multiple sclerosis immunopathology","volume":"22","author":"Grigoriadis","year":"2015","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jaut.2021.102702_bib76","first-page":"296","article-title":"Downregulation of immunosuppressive molecules, PD-1 and PD-L1 but not PD-L2, in the patients with multiple sclerosis","volume":"15","author":"Javan","year":"2016","journal-title":"Iran J Allergy Asthma Immunol."},{"key":"10.1016\/j.jaut.2021.102702_bib77","doi-asserted-by":"crossref","first-page":"4984","DOI":"10.4049\/jimmunol.0901038","article-title":"Costimulatory pathways in multiple sclerosis: distinctive expression of PD-1 and PD-L1 in patients with different patterns of disease","volume":"183","author":"Trabattoni","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2021.102702_bib78","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.pharmthera.2012.03.006","article-title":"Pharmacology and therapeutic potential of interferons","volume":"135","author":"George","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jaut.2021.102702_bib79","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ebiom.2019.09.059","article-title":"Interferon-\u03b2 corrects massive gene dysregulation in multiple sclerosis: short-term and long-term effects on immune regulation and neuroprotection","volume":"49","author":"Feng","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jaut.2021.102702_bib80","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jneuroim.2004.06.013","article-title":"Interferon-\u03b2 enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis","volume":"155","author":"Schreiner","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jaut.2021.102702_bib81","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1177\/1352458507081342","article-title":"Effects of interferon-\u03b2 on co-signaling molecules: upregulation of CD40, CD86 and PD-L2 on monocytes in relation to clinical response to interferon-\u03b2 treatment in patients with multiple sclerosis","volume":"14","author":"Wiesemann","year":"2008","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jaut.2021.102702_bib82","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/glia.21158","article-title":"The majority of infiltrating CD8 T lymphocytes in multiple sclerosis lesions is insensitive to enhanced PD-L1 levels on CNS cells","volume":"59","author":"Pittet","year":"2011","journal-title":"Glia"},{"key":"10.1016\/j.jaut.2021.102702_bib83","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1002\/eji.200738071","article-title":"B7-H1 restricts neuroantigen-specific T cell responses and confines inflammatory CNS damage: implications for the lesion pathogenesis of multiple sclerosis","volume":"38","author":"Ortler","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jaut.2021.102702_bib84","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/1742-2094-8-155","article-title":"Human brain endothelial cells endeavor to immunoregulate CD8 T cells via PD-1 ligand expression in multiple sclerosis","volume":"8","author":"Pittet","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jaut.2021.102702_bib85","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jneuroim.2016.08.013","article-title":"Contribution of EAE to understanding and treating multiple sclerosis","volume":"304","author":"Lovett-Racke","year":"2017","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jaut.2021.102702_bib86","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/B978-0-444-52001-2.00008-X","article-title":"The experimental autoimmune encephalomyelitis (EAE) model of MS. utility for understanding disease pathophysiology and treatment","volume":"122","author":"Robinson","year":"2014","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.jaut.2021.102702_bib87","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.2353\/ajpath.2009.081012","article-title":"Accelerated course of experimental autoimmune encephalomyelitis in PD-1-deficient central nervous system myelin mutants","volume":"174","author":"Kroner","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jaut.2021.102702_bib88","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.4049\/jimmunol.176.6.3480","article-title":"Differential role of programmed death-ligand 1 and programmed death-ligand 2 in regulating the susceptibility and chronic progression of experimental autoimmune encephalomyelitis","volume":"176","author":"Zhu","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2021.102702_bib89","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1523\/JNEUROSCI.4794-04.2005","article-title":"Microglial expression of the B7 family member B7 homolog 1 confers strong immune inhibition: implications for immune responses and autoimmunity in the CNS","volume":"25","author":"Magnus","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jaut.2021.102702_bib90","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1084\/jem.20022119","article-title":"Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis","volume":"198","author":"Salama","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2021.102702_bib91","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1002\/eji.200838137","article-title":"PD-1 ligands expressed on myeloid-derived APC in the CNS regulate T-cell responses in EAE","volume":"38","author":"Schreiner","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jaut.2021.102702_bib92","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jneuroim.2006.10.006","article-title":"PD-1\/PD-L1, but not PD-1\/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitis","volume":"182","author":"Carter","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jaut.2021.102702_bib93","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s12264-015-0010-9","article-title":"Programmed death ligand-1 on microglia regulates Th1 differentiation via nitric oxide in experimental autoimmune encephalomyelitis","volume":"32","author":"Hu","year":"2016","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.jaut.2021.102702_bib94","first-page":"7","article-title":"Down-modulation of programmed death 1 alters regulatory T cells and promotes experimental autoimmune encephalomyelitis","volume":"88","author":"Chunhe Wang","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jaut.2021.102702_bib95","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.immuni.2012.05.025","article-title":"Dendritic cells ameliorate autoimmunity in the CNS by controlling the homeostasis of PD-1 receptor+ regulatory T cells","volume":"37","author":"Yogev","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2021.102702_bib96","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.4049\/jimmunol.174.4.1888","article-title":"Prevention of experimental autoimmune encephalomyelitis by transfer of embryonic stem cell-derived dendritic cells expressing myelin oligodendrocyte glycoprotein peptide along with TRAIL or programmed death-1 ligand","volume":"174","author":"Hirata","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2021.102702_bib97","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jns.2009.05.028","article-title":"Estrogen treatment in multiple sclerosis","volume":"286","author":"Gold","year":"2009","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jaut.2021.102702_bib98","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2567.2008.03051.x","article-title":"Oestrogen modulates experimental autoimmune encephalomyelitis and interleukin-17 production via programmed death 1","volume":"126","author":"Wang","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.jaut.2021.102702_bib99","first-page":"143","article-title":"PD-1 interaction with PD-L1 but not PD-L2 on B-cells mediates protective effects of estrogen against EAE","author":"Bodhankar","year":"2013","journal-title":"J. Clin. Cell. Immunol."},{"key":"10.1016\/j.jaut.2021.102702_bib100","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s12974-019-1588-z","article-title":"Estrogen-induced compensatory mechanisms protect IL-10-deficient mice from developing EAE","volume":"16","author":"Seifert","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jaut.2021.102702_bib101","doi-asserted-by":"crossref","first-page":"577079","DOI":"10.1016\/j.jneuroim.2019.577079","article-title":"The change of PD1, PDL1 in experimental autoimmune encephalomyelitis treated by 1,25(OH)2D3","volume":"338","author":"Cao","year":"2020","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jaut.2021.102702_bib102","doi-asserted-by":"crossref","first-page":"102362","DOI":"10.1016\/j.jaut.2019.102362","article-title":"Dendritic cell upregulation of programmed death ligand-1 via DNA demethylation inhibits experimental autoimmune encephalomyelitis","volume":"107","author":"Bin Chang","year":"2020","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2021.102702_bib103","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3389\/fimmu.2015.00539","article-title":"Opposing roles of interferon-gamma on cells of the central nervous system in autoimmune neuroinflammation","volume":"6","author":"Ottum","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2021.102702_bib104","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3389\/fimmu.2015.00492","article-title":"Stage-specific role of interferon-gamma in experimental autoimmune encephalomyelitis and multiple sclerosis","volume":"6","author":"Arellano","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2021.102702_bib105","first-page":"75","volume":"vol. 185","author":"Cheng","year":"2007"},{"key":"10.1016\/j.jaut.2021.102702_bib106","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41598-017-18543-z","article-title":"Innate IFN-\u03b3 ameliorates experimental autoimmune encephalomyelitis and promotes myeloid expansion and PDL-1 expression","volume":"8","author":"White","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jaut.2021.102702_bib107","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jneuroim.2019.03.019","article-title":"The PD-1\/PD-Ls pathway is up-regulated during the suppression of experimental autoimmune encephalomyelitis treated by Astragalus polysaccharides","volume":"332","author":"Sun","year":"2019","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jaut.2021.102702_bib108","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.ijbiomac.2019.09.189","article-title":"Characterization and anti-tumor bioactivity of astragalus polysaccharides by immunomodulation","volume":"145","author":"Li","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jaut.2021.102702_bib109","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nri3447","article-title":"The good, the bad and the ugly - TFH cells in human health and disease","volume":"13","author":"Tangye","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jaut.2021.102702_bib110","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/ni.1877","article-title":"PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells","volume":"11","author":"Good-Jacobson","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2021.102702_bib111","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.immuni.2013.09.007","article-title":"Circulating precursor CCR7(lo)PD-1(hi) CXCR5+ CD4+ T cells indicate Tfh cell activity and promote antibody responses upon antigen reexposure","volume":"39","author":"He","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2021.102702_bib112","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/brain\/awm038","article-title":"Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology","volume":"130","author":"Magliozzi","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.jaut.2021.102702_bib113","doi-asserted-by":"crossref","first-page":"944","DOI":"10.3389\/fimmu.2018.00944","article-title":"T follicular helper-like cells are involved in the pathogenesis of experimental autoimmune encephalomyelitis","volume":"9","author":"Guo","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2021.102702_bib114","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3389\/fimmu.2018.00382","article-title":"Role of TFH cells in promoting T Helper 17-induced neuroinflammation","volume":"9","author":"Quinn","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2021.102702_bib115","doi-asserted-by":"crossref","first-page":"638968","DOI":"10.1155\/2015\/638968","article-title":"Follicular helper CD4+ T cells in human neuroautoimmune diseases and their animal models","author":"Fan","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.jaut.2021.102702_bib116","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/art.24227","article-title":"Genetic, immunologic, and immunohistochemical analysis of the programmed death 1\/programmed death ligand 1 pathway in human systemic lupus erythematosus","volume":"60","author":"Bertsias","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2021.102702_bib117","doi-asserted-by":"crossref","first-page":"36885","DOI":"10.18632\/oncotarget.16378","article-title":"Meta-analysis of programmed cell death 1 polymorphisms with systemic lupus erythematosus risk","volume":"8","author":"Gao","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jaut.2021.102702_bib118","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1046\/j.1399-0039.2003.00136.x","article-title":"Association of a putative regulatory polymorphism in the PD-1 gene with susceptibility to type 1 diabetes","volume":"62","author":"Nielsen","year":"2003","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jaut.2021.102702_bib119","first-page":"247637","article-title":"A promoter region polymorphism in PDCD-1 gene is associated with risk of rheumatoid arthritis in the Han Chinese population of southeastern China","author":"Liu","year":"2014","journal-title":"Int. J. Genomics. 2014"},{"key":"10.1016\/j.jaut.2021.102702_bib120","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/art.20966","article-title":"A new haplotype of PDCD1 is associated with rheumatoid arthritis in Hong Kong Chinese","volume":"52","author":"Kong","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2021.102702_bib121","doi-asserted-by":"crossref","first-page":"R136","DOI":"10.1186\/ar2071","article-title":"Association of the programmed cell death 1 (PDCD1) gene polymorphism with ankylosing spondylitis in the Korean population","volume":"8","author":"Lee","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2021.102702_bib122","first-page":"13","article-title":"Association of polymorphisms in the programmed cell death 1 (PD-1) and PD-1 ligand genes with ankylosing spondylitis in a Chinese population","volume":"29","author":"Yang","year":"2011","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2021.102702_bib123","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00776-014-0648-6","article-title":"The programmed cell death 1 gene polymorphisms (PD 1.3 G\/A, PD 1.5 C\/T and PD 1.9 C\/T) and susceptibility to ankylosing spondylitis: a meta-analysis","volume":"20","author":"Yang","year":"2015","journal-title":"J. Orthop. Sci."},{"key":"10.1016\/j.jaut.2021.102702_bib124","first-page":"1614683","article-title":"Association of PD-1 and PD-L1 genetic polymorphyisms with type 1 diabetes susceptibility","author":"Qian","year":"2018","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.jaut.2021.102702_bib125","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1530\/EJE-07-0649","article-title":"Association of an A\/C single nucleotide polymorphism in programmed cell death-ligand 1 gene with Graves' disease in Japanese patients","volume":"158","author":"Hayashi","year":"2008","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.jaut.2021.102702_bib126","doi-asserted-by":"crossref","first-page":"5139","DOI":"10.1210\/jc.2009-1404","article-title":"Programmed death ligand 1 (PD-L1) gene variants contribute to autoimmune Addison\u2019s disease and Graves\u2019 disease susceptibility","volume":"94","author":"Mitchell","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jaut.2021.102702_bib127","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s10875-007-9113-z","article-title":"Polymorphisms of genes for programmed cell death 1 ligands in patients with rheumatoid arthritis","volume":"27","author":"Wang","year":"2007","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.jaut.2021.102702_bib128","first-page":"721","article-title":"Ligands for programmed cell death 1 gene in patients with systemic lupus erythematosus","volume":"34","author":"Wang","year":"2007","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2021.102702_bib129","first-page":"406136","article-title":"Variable increased expression of program death-1 and program death-1 ligands on peripheral mononuclear cells is not impaired in patients with systemic lupus erythematosus","author":"Liu","year":"2009","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.jaut.2021.102702_bib130","first-page":"3297","article-title":"Elevated expression of PD-1 on T cells correlates with disease activity in rheumatoid arthritis","volume":"17","author":"Luo","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.jaut.2021.102702_bib131","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.4049\/jimmunol.171.8.4156","article-title":"Blockade of B7-H1 suppresses the development of chronic intestinal inflammation","volume":"171","author":"Kanai","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2021.102702_bib132","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1007\/s12026-016-8880-0","article-title":"The role of B7 family costimulatory molecules and indoleamine 2,3-dioxygenase in primary Sj\u00f6gren\u2019s syndrome and systemic sclerosis","volume":"65","author":"Leg\u00e1ny","year":"2017","journal-title":"Immunol. Res."},{"key":"10.1016\/j.jaut.2021.102702_bib133","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/j.1464-5491.2006.01951.x","article-title":"Phenotypic and genetic analyses of T-cell-mediated immunoregulation in patients with Type 1 diabetes","volume":"23","author":"Tsutsumi","year":"2006","journal-title":"Diabet. Med."},{"key":"10.1016\/j.jaut.2021.102702_bib134","doi-asserted-by":"crossref","first-page":"dgaa130","DOI":"10.1210\/clinem\/dgaa130","article-title":"PD-1 and PD-L1 expression in peripheral CD4\/CD8+ T cells is restored in the partial remission phase in type 1 diabetes","volume":"105","author":"Li","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jaut.2021.102702_bib135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183887","article-title":"Programmed cell death-1, PD-1, is dysregulated in T cells from children with new onset type 1 diabetes","volume":"12","author":"Granados","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.jaut.2021.102702_bib136","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13075-016-0942-0","article-title":"PD-L1-expressing neutrophils as a novel indicator to assess disease activity and severity of systemic lupus erythematosus","volume":"18","author":"Luo","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2021.102702_bib137","doi-asserted-by":"crossref","first-page":"155119","DOI":"10.1016\/j.cyto.2020.155119","article-title":"Low expressions of PD-L1 and CTLA-4 by induced CD4+CD25+ Foxp3+ Tregs in patients with SLE and their correlation with the disease activity","volume":"133","author":"Zhao","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.jaut.2021.102702_bib138","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1093\/rheumatology\/ken256","article-title":"Active systemic lupus erythematosus is associated with failure of antigen-presenting cells to express programmed death ligand-1","volume":"47","author":"Mozaffarian","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2021.102702_bib139","doi-asserted-by":"crossref","first-page":"8844","DOI":"10.4049\/jimmunol.177.12.8844","article-title":"Aberrant regulation of synovial T cell activation by soluble costimulatory molecules in rheumatoid arthritis","volume":"177","author":"Wan","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2021.102702_bib140","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.139032","article-title":"Pathogenic, glycolytic PD-1+ B cells accumulate in the hypoxic RA joint","volume":"5","author":"Floudas","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaut.2021.102702_bib141","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1186\/s13075-014-0497-x","article-title":"Synovial T cell hyporesponsiveness to myeloid dendritic cells is reversed by preventing PD-1\/PD-L1 interactions","volume":"16","author":"Moret","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2021.102702_bib142","first-page":"2156","article-title":"Enhanced expression of programmed death-1 (PD-1)\/PD-L1 in salivary glands of patients with Sj\u00f6gren\u2019s syndrome","volume":"32","author":"Kobayashi","year":"2005","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2021.102702_bib143","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1572-0241.2006.00948.x","article-title":"Expression of PD-1, PD-L1, and PD-L2 in the liver in autoimmune liver diseases","volume":"102","author":"Mataki","year":"2007","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jaut.2021.102702_bib144","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1440-1827.2007.02129.x","article-title":"Intrahepatic expression of the co-stimulatory molecules programmed death-1, and its ligands in autoimmune liver disease","volume":"57","author":"Oikawa","year":"2007","journal-title":"Pathol. Int."},{"key":"10.1016\/j.jaut.2021.102702_bib145","doi-asserted-by":"crossref","first-page":"256","DOI":"10.5114\/ceh.2019.87642","article-title":"Hepatic expression of programmed death-1 (PD-1) and its ligand, PD-L1, in children with autoimmune hepatitis: relation to treatment response","volume":"5","author":"Agina","year":"2019","journal-title":"Clin. Exp. Hepatol."},{"key":"10.1016\/j.jaut.2021.102702_bib146","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1093\/intimm\/10.10.1563","article-title":"Immunological studies on PD-1-deficient mice: implication of PD-1 as a negative regulator for B cell responses","volume":"10","author":"Nishimura","year":"1998","journal-title":"Int. Immunol."},{"key":"10.1016\/j.jaut.2021.102702_bib147","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1074-7613(00)80089-8","article-title":"Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor","volume":"11","author":"Nishimura","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2021.102702_bib148","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1126\/science.291.5502.319","article-title":"Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice","volume":"291","author":"Tanaka","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.jaut.2021.102702_bib149","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1084\/jem.20051776","article-title":"Tissue expression of PD-L1 mediates peripheral T cell tolerance","volume":"203","author":"Keir","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2021.102702_bib150","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1002\/art.27500","article-title":"The programmed death 1\/programmed death ligand 1 inhibitory pathway is up-regulated in rheumatoid synovium and regulates peripheral T cell responses in human and murine arthritis","volume":"62","author":"Raptopoulou","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2021.102702_bib151","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1074-7613(04)00050-0","article-title":"B7-H1 determines accumulation and deletion of intrahepatic CD8+ T lymphocytes","volume":"20","author":"Dong","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2021.102702_bib152","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.4049\/jimmunol.181.4.2513","article-title":"Programmed death ligand 1 regulates a critical checkpoint for autoimmune myocarditis and pneumonitis in MRL mice","volume":"181","author":"Lucas","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2021.102702_bib153","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/intimm\/dxq026","article-title":"PD-1 deficiency results in the development of fatal myocarditis in MRL mice","volume":"22","author":"Wang","year":"2010","journal-title":"Int. Immunol."},{"key":"10.1016\/j.jaut.2021.102702_bib154","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.3390\/ijms22031426","article-title":"Programmed death-ligand 2 deficiency exacerbates experimental autoimmune myocarditis in mice","volume":"22","author":"Li","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jaut.2021.102702_bib155","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1084\/jem.20022125","article-title":"The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice","volume":"198","author":"Ansari","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2021.102702_bib156","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.4049\/jimmunol.0901652","article-title":"Anti-Programmed cell death 1 antibody reduces CD4+ PD-1+ T cells and relieves the lupus-like nephritis of NZB\/W F1 mice","volume":"184","author":"Kasagi","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2021.102702_bib157","doi-asserted-by":"crossref","first-page":"5402","DOI":"10.4049\/jimmunol.1202382","article-title":"Blockade of programmed death-1 in young (New Zealand black \u00d7 New Zealand white)F1 mice promotes the suppressive capacity of CD4+ regulatory T cells protecting from lupus-like disease","volume":"190","author":"Wong","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2021.102702_bib158","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.clim.2005.10.017","article-title":"Delivering PD-1 inhibitory signal concomitant with blocking ICOS co-stimulation suppresses lupus-like syndrome in autoimmune BXSB mice","volume":"118","author":"Ding","year":"2006","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jaut.2021.102702_bib159","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1136\/gutjnl-2014-307311","article-title":"Protective effects of Fc-fused PD-L1 on two different animal models of colitis","volume":"64","author":"Song","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2021.102702_bib160","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/gt.2015.18","article-title":"\u03b2-cell-targeted blockage of PD1 and CTLA4 pathways prevents development of autoimmune diabetes and acute allogeneic islets rejection","volume":"22","author":"El Khatib","year":"2015","journal-title":"Gene Ther."},{"key":"10.1016\/j.jaut.2021.102702_bib161","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aam7543","article-title":"PD-L1 genetic overexpression or pharmacological restoration in hematopoietic stem and progenitor cells reverses autoimmune diabetes","volume":"9","author":"Ben Nasr","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jaut.2021.102702_bib162","article-title":"Engineered PD-L1-expressing platelets reverse new-onset type 1 diabetes","volume":"32","author":"Zhang","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jaut.2021.102702_bib163","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/art.25032","article-title":"Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus","volume":"62","author":"Simpson","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2021.102702_bib164","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/cei.12162","article-title":"High frequencies of activated B cells and T follicular helper cells are correlated with disease activity in patients with new-onset rheumatoid arthritis","volume":"174","author":"Wang","year":"2013","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2021.102702_bib165","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.clim.2013.02.024","article-title":"Follicular helper T cells may play an important role in the severity of primary Sj\u00f6gren\u2019s syndrome","volume":"147","author":"Szabo","year":"2013","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jaut.2021.102702_bib166","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.bbrc.2012.04.133","article-title":"Role of the frequency of blood CD4+ CXCR5+ CCR6+ T cells in autoimmunity in patients with Sj\u00f6gren\u2019s syndrome","volume":"422","author":"yi Li","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jaut.2021.102702_bib167","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2337\/db16-0714","article-title":"Circulating CXCR5+PD-1+ICOS+ Follicular T helper cells are increased close to the diagnosis of type 1 diabetes in children with multiple autoantibodies","volume":"66","author":"Viisanen","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.jaut.2021.102702_bib168","first-page":"7","article-title":"Constitutive changes in circulating follicular helper T cells and their subsets in patients with graves disease","author":"Liu","year":"2018","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.jaut.2021.102702_bib169","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1080\/08916934.2018.1516761","article-title":"Increased circulating Tfh17 and PD-1+ Tfh cells are associated with autoantibodies in Hashimoto\u2019s thyroiditis","volume":"51","author":"Zhao","year":"2018","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jaut.2021.102702_bib170","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jneuroim.2012.12.001","article-title":"Expansion of circulating counterparts of follicular helper T cells in patients with myasthenia gravis","volume":"256","author":"Luo","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jaut.2021.102702_bib171","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jneuroim.2014.11.011","article-title":"Association of circulating follicular helper T cells with disease course of NMO spectrum disorders","volume":"278","author":"Li","year":"2015","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jaut.2021.102702_bib172","first-page":"631787","article-title":"The histopathology of labial salivary glands in primary sj\u00f6gren\u2019s syndrome: focusing on follicular helper T cells in the inflammatory infiltrates","author":"Szabo","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.jaut.2021.102702_bib173","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/cei.12703","article-title":"A comprehensive investigation on the distribution of circulating follicular T helper cells and B cell subsets in primary Sj\u00f6gren\u2019s syndrome and systemic lupus erythematosus","volume":"183","author":"Szab\u00f3","year":"2016","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2021.102702_bib174","doi-asserted-by":"crossref","DOI":"10.1111\/sji.12679","article-title":"T follicular-like helper cells in the peripheral blood of patients with primary Sj\u00f6gren\u2019s syndrome","volume":"88","author":"Brokstad","year":"2018","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.jaut.2021.102702_bib175","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature20810","article-title":"Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis","volume":"542","author":"Rao","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2021.102702_bib176","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1007\/s00125-019-4936-8","article-title":"Circulating CXCR5\u2212PD-1hi peripheral T helper cells are associated with progression to type 1 diabetes","volume":"62","author":"Ekman","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/j.jaut.2021.102702_bib177","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.130062","article-title":"PD-1hiCXCR5- T peripheral helper cells promote B cell responses in lupus via MAF and IL-21","volume":"4","author":"Bocharnikov","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaut.2021.102702_bib178","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1074\/jbc.RA118.005874","article-title":"Membrane-associated epithelial cell adhesion molecule is slowly cleaved by -secretase prior to efficient proteasomal degradation of its intracellular domain","volume":"294","author":"Huang","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jaut.2021.102702_bib179","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3390\/molecules25030671","article-title":"Proteasome inhibitors: harnessing proteostasis to combat disease","volume":"25","author":"Sherman","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.jaut.2021.102702_bib180","doi-asserted-by":"crossref","first-page":"FSO11","DOI":"10.4155\/fso.15.9","article-title":"The role and therapeutic targeting of \u03b1-, \u03b2-and \u03b3-secretase in Alzheimer's disease","volume":"1","author":"Macleod","year":"2015","journal-title":"Futur. Sci. OA."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841121001104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841121001104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:30:25Z","timestamp":1760257825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841121001104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":180,"alternative-id":["S0896841121001104"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2021.102702","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cellular and molecular regulation of the programmed death-1\/programmed death ligand system and its role in multiple sclerosis and other autoimmune diseases","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2021.102702","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102702"}}